Benchmark Maintains Buy on Cross Country Healthcare, Raises Price Target to $40
Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and raises the price target from $45 to $40.
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
Barrington Research Maintains Outperform on Cross Country Healthcare, Raises Price Target to $45
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and raises the price target from $41 to $45.
Denbury, Global-e Online And Agilent Among Top Gainers On Wednesday
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping around 170 points. Here is the list of some big stocks moving higher in the previous session.
This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Benchmark Maintains Buy Rating for Cross Country Healthcare: Here’s What You Need To Know
Benchmark has decided to maintain its Buy rating of Cross Country Healthcare (NASDAQ:CCRN) and lower its price target from $42.00 to $37.00.
Shares of Cross Country Healthcare are trading down 6.22% over the last 24 hours, at $17.33 per share.